Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade

Journal:
Cancer Research
Published:
DOI:
10.1158/0008-5472.can-20-0434
Affiliations:
5
Authors:
19
Institutions Authors Share
Genmab B.V., Netherlands
8.000000
0.42
Netherlands Cancer Institute (NKI), Netherlands
5.500000
0.29
Oncode Institute, Netherlands
4.500000
0.24
Genmab US, Inc., United States of America (USA)
1.000000
0.05